From October 1, 2022 to December 31, 2022, the company has repurchased 827,300 shares, representing 0.1% for CNY 31.5 million. With this, the company has completed the repurchase of 1,257,300 shares, representing 0.15% for CNY 47.3 million under the buyback announced on September 1, 2022.
End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
16.12 CNY | +0.06% | +6.68% | -33.42% |
EPS Revisions
Annual profits - Rate of surprise
1st Jan change | Capi. | |
---|---|---|
-33.42% | 2B | |
+26.92% | 681B | |
+21.85% | 556B | |
-5.01% | 361B | |
+17.13% | 325B | |
+5.23% | 285B | |
+13.68% | 235B | |
+3.65% | 199B | |
-11.12% | 189B | |
-4.17% | 157B |
- Stock Market
- Equities
- 603456 Stock
- News Zhejiang Jiuzhou Pharmaceutical Co., Ltd
- Tranche Update on Zhejiang Jiuzhou Pharmaceutical Co., Ltd's Equity Buyback Plan announced on September 1, 2022.